Connecticut Cannabis Sales

Among small-tier Northeast markets, Connecticut's 3.8% year-over-year sales growth trails the pace set by neighbors that are scaling faster from larger bases. The state added nine dispensaries over the past year, pushing the count to 69, but an 11.3% drop in average pricing means each new storefront is generating thinner margins. Two-year cumulative growth of just 3.1% underscores how tightly supply-side expansion and price erosion have offset each other.

24-Month Trend

State	Sales	YoY
Louisiana	$25-35M	86.3%
Arkansas	$25-35M	0.8%
Connecticut	$25-35M	3.8%
Utah	$15-20M	7.9%
Alaska	$15-20M	9.1%

Benchmarking

Market ComparisonApr 2026

Among small-tier Northeast markets, Connecticut's 3.8% year-over-year sales growth trails the pace set by neighbors that are scaling faster from larger bases. The state added nine dispensaries over the past year, pushing the count to 69, but an 11.3% drop in average pricing means each new storefront is generating thinner margins. Two-year cumulative growth of just 3.1% underscores how tightly supply-side expansion and price erosion have offset each other.

24-Month Trend

State	Sales	YoY
Louisiana	$25-35M	+86.3%
Arkansas	$25-35M	+0.8%
Connecticut	$25-35M	+3.8%
Utah	$15-20M	+7.9%
Alaska	$15-20M	-9.1%

Top performing dispensaries in Connecticut.

Store	City	Est. Sales
#1 Fine Fettle - Newington	Newington	$1-2.5M
#2 Zen Leaf - Waterbury	Waterbury	$1-2.5M
#3 Fine Fettle - Willimantic	Willimantic	$.5M-1M
#4 RISE Dispensary - Branford	Branford	$.5M-1M
#5 Budr Cannabis - Stratford	Stratford	$.5M-1M

Pre-rolls are Connecticut's fastest-moving segment, surging 14% year over year to capture nearly 15% of market share, while flower remains the top category at 35.6% share and posted healthy 7.6% growth. Edibles gained ground as well, rising 6.7% to hold 15.6% of sales. Vapes, the second-largest category at 32.9% share, slipped 3% as consumers shifted toward combustible and ingestible formats. Concentrates remain a niche at just over 1% of the market, declining nearly 15% year over year—a segment where Theraplant and other operators have yet to build meaningful consumer traction.

Category	Sales	Avg Price	YoY
#1Flower	$5-10M	$40.01	7.6%
#2Vapes	$5-10M	$43.24	3.0%
#3Edibles	$2.5-5M	$20.74	6.7%
#4Pre-Rolls	$2.5-5M	$17.2	14.0%
#5Concentrates	$250-500K	$37.31	14.8%
#6Oral	<$250K	$36	27.3%
#7Accessories	<$250K	$6.46	8.3%
#8Topicals	<$250K	$23.74	7.7%
#9Cbd	<$250K	$24.02	74.5%